- 英文名称
- Voglibose
- 分子式
- C10H21NO7
- 分子量
- 267.28
- 中文别名
- 伏利多糖; 伏利波糖; 伏格利波糖; 5-(1,3-二羟基丙烷-2-基氨基)-1-(羟甲基)-1,2,3,4-环己四醇; (1S,2S,3R,4S,5S)-5-((1,3-二羟丙基-2-基)氨基)-1-(羟甲基)环己烷-1,2,3,4-四醇; Voglistat; epi-Inositol, 2,3-dideoxy-2-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-4-C-(hydroxymethyl)-; 2,3-Dideoxy-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-4-C-(hydroxymethyl)-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine; Basen; AO 128; Glustat; (1S,2S,3R,4S,5S)-5-[(1,3-Dihydroxy-2-propanyl)amino]-1-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol; Voglibose (JP15/USAN); 3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol; (1S,2S,3R,4S,5S)-5-[(1,3-Dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; (1S,2S,3R,4S,5S)-5-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; N-(1,3-Dihydroxy-2-propyl)valiolamine
- 用途
- 伏格列波糖是一种口服降血糖药，属于α-葡萄糖苷酶抑制剂，用于治疗糖尿病，改善餐后高血糖，通过抑制肠道内双糖类水解酶延缓碳水化合物吸收，适用于中老年糖尿病患者及多种糖尿病并发症患者，副作用较少，可用于轻中度肝功能异常患者。
